Researchers continue to excited about this new drug, a novel dual compound showing significant results in clinical trials for size loss . It works by impacting several pathways : GLP-1 and GIP, which , when activated , help influence cravings and boost energy expenditure . Early observations suggest noteworthy weight loss and possible improvements